Retatrutide vs Semaglutide for weight loss
Short answer: For weight loss, more users report improvement with Retatrutide — 92% of 228 reports, versus 85% of 138 for Semaglutide.
Retatrutide has 22 meta-analyses and 6 randomized trials on PubMed; Semaglutide has 421 and 307.
Based on 460 reports about Retatrutide and 330 about Semaglutide. Not medical advice.
| Retatrutide Peptide | Semaglutide Medication | |
|---|---|---|
| Users say it helped | 76%helped327 reports · high confidence | 64%helped228 reports · high confidence |
| Verdict | Mostly positive | Mostly positive |
| Research | BResearch: Moderate | AResearch: Strong |
| Meta-analyses / RCTs | 22 / 6 | 421 / 307 |
| Mainly used for | ||
| Weight loss % reporting improvement | 92% (228) | 85% (138) |
| Appetite % reporting improvement | 73% (86) | 80% (70) |
| Energy % reporting improvement | 69% (75) | 39% (23) |
| Mood % reporting improvement | 66% (32) | 27% (11) |
| Performance % reporting improvement | 82% (33) | 83% (6) |
| Common side effects | nausea, fatigue, stomach issues, insomnia | nausea, fatigue, stomach issues, constipation |
| Typical dose reported | Not listed | Not listed |
This systematic review identifies the state and mechanism of action of emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials. The information provided herein furthers the understanding of obesity management, implying direct clinical implications and stimulating research initiatives.
Pharmacol Rev, 2025 ↗“Drastically reduced appetite: At 5mg, I experienced near-total suppression of hunger and cravings. Steady, effortless fat loss: I didn't have to track macros obsessively or do extreme cardio.”
This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.
Pharmacol Res, 2021 ↗“I've lost 35lbs since then and now I'm in the Healthy range on BMI. My IBSD has virtually disappeared.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate